Come up with a name for your new list and we'll add to it:
OxThera raised a round of funding on September 25, 2013. Investors include
Seventh Framework Programme.
OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera's intellectual property includes worldwide patents for …